Browsing by Author "Esser, M."

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Angio-oedema associated with colistin
    (Health & Medical Publishing Group, 2016) Abulfathi, A. A.; Greyling, T.; Makiwane, M.; Esser, M.; Decloedt, E.
    ENGLISH ABSTRACT: A 50-year-old woman known to have type 1 diabetes mellitus presented with a rare case of angio-oedema associated with colistin use. The angio-oedema was temporally associated with the use and discontinuation of colistin with the reasonable exclusion of important differential diagnoses. Pseudoallergy may be a probable underlying mechanism. However, we cannot exclude the possibility of hereditary angio-oedema type 2 or 3, or that her concomitant medications (particularly enalapril) and her renal impairment contributed to the risk and severity of her angio-oedema.
  • Thumbnail Image
    Item
    HIV sero-conversion during late pregnancy - when to retest
    (AOSIS, 2013) Kalk, E.; Slogrove, Amy L.; Speert, D.; Bettinger, J.; Cotton, M. F.; Esser, M.
    The South African National Prevention of Mother-to-Child Transmission of HIV programme has resulted in significant reductions in vertical transmission, but new infant HIV infections continue to occur. We present two cases of HIV seroconversion during late pregnancy, demonstrating the limitations of the current programme. These could be mitigated by expanding the programme to include maternal testing at delivery and at immunisation clinic visits as we pursue the elimination of mother-tochild transmission.
  • Thumbnail Image
    Item
    Investigation and management of primary immunodeficiency in South African children
    (Health and Medical Publishing Group, 2014) Eley, B.; Esser, M.
    ENGLISH ABSTRACT: The primary immunodeficiency diseases (PIDs) are inherited, non-communicable diseases that cause immunological dysfunction. PIDs are seldom reported in South Africa (SA). Based on a mid-2013 population estimate of 52.98 million and assuming that the prevalence of PIDs is similar to that in well-resourced settings, the total number of individuals with PIDs in our country should range between 2 850 and 45 723. However, fewer than 500 cases of PID have been reported in SA. Between five and 15 new, fully characterised PIDs are reported annually. Our understanding of the physiology of the immune system has been substantially enhanced by these discoveries, and consequently the international classification of PIDs has been updated.
  • Thumbnail Image
    Item
    Involving African traditional health practitioners in HIV/AIDS interventions
    (Health and Medical Publishing Group (HMPG), 2008) Wreford, J.; Esser, M.
    [No abstract available]
  • Thumbnail Image
    Item
    Neurodevelopmental status of HIV-exposed but uninfected children : a pilot study
    (Health & Medical Publishing Group, 2012-03-29) Springer, P.; Laughton, Barbara; Tomlinson, M.; Harvey, J.; Esser, M.
    Introduction. HIV affects children both directly and indirectly, with evidence of increased infectious mortality and morbidity in the HIV-exposed but uninfected (HEU) infant. There is little published research on neurodevelopmental outcome of HEU infants in Africa. Following the introduction of successful prevention of mother-to-child transmission programmes, it has become important to determine whether differences exist between HEU infants and infants born to HIV-negative mothers in order to guide current management policies of this rapidly growing group of infants. Objectives. To compare the developmental outcome of infants exposed to HIV in utero who remained uninfected (HEU) with that of infants unexposed to HIV in utero (HUU). Methodology. This was a prospective, blinded, hospital-based study. Infants aged between 17 and 19 months were assessed on the Griffiths Mental Developmental Scales (GMDS). Birth history, previous hospitalisation, maternal and infant characteristics, antiretroviral exposure, anthropometric measurements and abnormal clinical findings were documented. Results. Of the original 55 infants enrolled at 2 weeks of age, 37 (17 HEU and 20 HUU) underwent neurological and developmental assessment. There were no significant differences between the groups with regard to the GMDS general quotient or other subscales, apart from the Personal/social subscale, where the HEU group performed significantly more poorly than the HUU participants (p=0.026). This difference is probably a result of cultural differences between the groups, as 76% of HEU and only 15% of HUU participants were of Xhosa origin. Discussion. There was no difference in neurodevelopmental outcome at 18 months between the HEU and HUU groups.